SLC22A1-ABCB1 Haplotype Profiles Predict Imatinib Pharmacokinetics in Asian Patients with Chronic Myeloid Leukemia. The gene discussed is SLC22A1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.